Active Ingredient(s): Dexrazoxane Hydrochloride
FDA Approved: * September 6, 2007
Pharm Company: * TOPOTARGET
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Totect Overview

Dexrazoxane hydrochloride (Zinecard, Cardioxane) is a cardioprotective agent. It was discovered by Eugene Herman in 1972. The IV administration of dexrazoxane is in acidic condition with HCl adjusting the pH.[1] Contents 1 Uses 2 Mechanism 3 References 4 External links Uses Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of chemotherapeutic drugs such as anthracyclines,[2] such as daunorubicin or doxorubicin or other c...

Read more Totect Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Totect Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dexrazoxane Hydrochloride
  • Injection: 250mg, 250mg/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Totect: (3 results)

Sorted by National Drug Code
  • 38423-110 Totect Intravenous Kit by Topotarget USA
  • 66220-110 Totect 500 mg Intravenous Injection, Powder, Lyophilized, for Solution by Cumberland Pharmaceuticals Inc.
  • 76310-110 Totect 500 mg Intravenous Injection, Powder, Lyophilized, for Solution by Clinigen Group Plc

Other drugs which contain Dexrazoxane Hydrochloride or a similar ingredient: (2 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 27 July 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA